Robert Henk Henning

Title: The Innovations of Robert Henk Henning

Introduction

Robert Henk Henning is a notable inventor based in Loppersum, Netherlands. He has made significant contributions to the field of medicine, particularly in the treatment of cardiac failure. His innovative approach has led to the development of a unique patent that addresses a critical health issue.

Latest Patents

Robert Henk Henning holds a patent for the "Use of erythropoietin for the preventive or curative treatment of cardiac failure." This patent outlines the uses of erythropoietin, or its derivatives, for creating a medicament aimed at preventing or curing patients suffering from, or at risk of, cardiac failure. This innovative treatment has the potential to improve the quality of life for many individuals facing this serious condition. He has 1 patent to his name.

Career Highlights

Throughout his career, Henning has worked with various organizations that focus on medical research and development. Notably, he has been associated with Crucell Holland B.V. and Stichting Klinische Farmacologie Groningen. His work in these institutions has allowed him to collaborate with other experts in the field and contribute to groundbreaking research.

Collaborations

Henning has collaborated with notable professionals such as Wiekert Hendrikus Van Gilst and Rudolf Allert De Boer. These collaborations have enriched his research and have played a significant role in the advancement of his innovative ideas.

Conclusion

Robert Henk Henning's contributions to the field of medicine through his patent on erythropoietin exemplify the impact of innovation in healthcare. His work continues to inspire advancements in the treatment of cardiac failure, showcasing the importance of research and collaboration in the medical field.